Kyverna Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -530 | -482 | -462 | |
EBITDA | -33,902 | -28,234 | -26,167 | -20,158 |
EBIT | -34,460 | -28,764 | -26,649 | -20,620 |
Net Income | -34,492 | -28,803 | -26,693 | -20,667 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -27,591 | -25,203 | -26,068 | -18,897 |
Cash | 104,663 | 131,618 | 224,287 | 34,647 |
Basic Shares | 43,155 | 43,125 | 23,754 | 43,115 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $7,025 | $5,656 |
Gross Profit | -1,707 | 5,974 | 5,070 |
EBITDA | -58,472 | -27,777 | -25,761 |
EBIT | -60,179 | -28,828 | -26,347 |
Net Income | -60,366 | -28,893 | -26,350 |
Net Change In Cash | 0 | 7,025 | 5,656 |
Free Cash Flow | -53,031 | -36,881 | -23,444 |
Cash | 34,647 | 37,735 | 76,067 |
Basic Shares | 673,622 | 25,803 | 25,803 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.80 |
2024-06-30 | -$0.67 |
2024-03-31 | -$1.12 |
2023-12-31 | -$26.86 |
